Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305286
Status:
RECRUITING
Last Update Posted:
2024-03-27
First Post:
2024-02-16
Brief Title:
Safety Tolerability and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus T1D
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
IRB23-1367
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cure Alliance | UNKNOWN |
| Juvenile Diabetes Research Foundation | OTHER |